Impulsivity in Gambling Disorder and problem gambling: a meta-analysis.
Journal
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
10
02
2019
accepted:
09
04
2019
revised:
25
03
2019
pubmed:
16
4
2019
medline:
1
4
2020
entrez:
16
4
2019
Statut:
ppublish
Résumé
Gambling Disorder is a prevalent psychiatric condition often linked to dysfunction of cognitive domains regulating impulsive behavior. Despite the centrality of impulsivity to neurobiological models of Gambling Disorder, a comprehensive meta-analysis of all impulsive cognitive domains has yet to be conducted. It is also not clear whether cognitive deficits in Gambling Disorder extend to those with problem (at-risk) gambling. A systematic review was undertaken of case-control studies examining the following cognitive domains in Gambling Disorder or in at-risk (problem) gambling: attentional inhibition, motor inhibition, discounting, decision-making, and reflection impulsivity. Case-control differences in cognition were identified using meta-analysis (random-effects modeling). Moderation analysis explored potential influences of age, gender, presence/absence of comorbidities in cases, geographical region, and study quality on cognitive performance. Gambling Disorder was associated with significant impairments in motor (g = 0.39-0.48) and attentional (g = 0.55) inhibition, discounting (g = 0.66), and decision-making (g = 0.63) tasks. For problem gambling, only decision-making had sufficient data for meta-analysis, yielding significant impairment versus controls (g = 0.66); however, study quality was relatively low. Insufficient data were available for meta-analysis of reflection impulsivity. There was evidence for significant publication bias only for the discounting domain, after an outlier study was excluded. Study quality overall was reasonable (mean score 71.9% of maximum), but most studies (~85%) did not screen for comorbid impulse control and related disorders. This meta-analysis indicates heightened impulsivity across a range of cognitive domains in Gambling Disorder. Decision-making impulsivity may extend to problem (at-risk) gambling, but further studies are needed to confirm such candidate cognitive vulnerability markers.
Identifiants
pubmed: 30986818
doi: 10.1038/s41386-019-0393-9
pii: 10.1038/s41386-019-0393-9
pmc: PMC6588525
mid: EMS82616
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1354-1361Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 110049
Pays : United Kingdom
Références
J Psychiatr Res. 2012 Sep;46(9):1206-11
pubmed: 22726595
Curr Opin Neurobiol. 2013 Aug;23(4):655-9
pubmed: 23375671
J Gambl Stud. 2018 Jun;34(2):429-447
pubmed: 28770486
eNeuro. 2017 Jun 13;4(3):
pubmed: 28612049
Addiction. 2015 Aug;110(8):1340-51
pubmed: 25879250
Am J Addict. 2015 Apr;24(3):206-216
pubmed: 25864783
Psychiatry Res. 2015 Mar 30;226(1):273-6
pubmed: 25660732
Psychol Med. 2018 Apr;48(5):810-821
pubmed: 28805173
Nature. 2018 Mar 1;555(7694):30
pubmed: 29493605
Neuroimage. 2019 Nov 15;202:116070
pubmed: 31382045
J Clin Exp Neuropsychol. 2018 Feb;40(1):45-61
pubmed: 28398126
Neurosci Biobehav Rev. 2018 Jan;84:204-217
pubmed: 29203423
Drug Alcohol Depend. 2017 Dec 1;181:152-161
pubmed: 29055269
Psychol Med. 2014 Jul;44(10):2029-40
pubmed: 24168753
Addiction. 2013 Mar;108(3):575-81
pubmed: 22994319
Psychopharmacology (Berl). 2016 Sep;233(18):3361-70
pubmed: 27449350
Cogn Behav Neurol. 2003 Mar;16(1):47-53
pubmed: 14765001
Neuropsychobiology. 2014;70(2):95-102
pubmed: 25359489
Addict Biol. 2017 Jul;22(4):885-897
pubmed: 26935000
Compr Psychiatry. 2016 Jul;68:111-8
pubmed: 27234191
Psychiatry Res. 2005 Jan 30;133(1):91-9
pubmed: 15698681
Int J Ment Health Addict. 2015;13(6):699-711
pubmed: 26568706
Addict Behav. 2014 Nov;39(11):1632-1639
pubmed: 24864028
Psychol Med. 2014 Apr;44(6):1121-30
pubmed: 23866289
PLoS One. 2013 Jun 20;8(6):e65566
pubmed: 23840340
Psychiatry Res. 2011 Aug 30;189(1):115-20
pubmed: 21715016
Neurosci Biobehav Rev. 2016 Dec;71:252-266
pubmed: 27590829
Addiction. 2017 Jan;112(1):51-62
pubmed: 27450931
Addiction. 2019 Jun;114(6):1095-1109
pubmed: 30133930
Addiction. 2009 Jun;104(6):1006-15
pubmed: 19466924
Front Psychol. 2018 Aug 02;9:1339
pubmed: 30123154
J Gambl Stud. 2015 Dec;31(4):1201-14
pubmed: 25424057
Lancet. 2011 Nov 26;378(9806):1874-84
pubmed: 21600645
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
CNS Spectr. 2019 Aug;24(4):426-440
pubmed: 30458896
Nat Rev Neurosci. 2017 Feb 17;18(3):158-171
pubmed: 28209979
Aust N Z J Psychiatry. 2015 Sep;49(9):851
pubmed: 25916798
Psychopharmacology (Berl). 1999 Oct;146(4):348-61
pubmed: 10550486
Aust N Z J Psychiatry. 2019 Sep;53(9):896-907
pubmed: 31001986
Sci Rep. 2016 Dec 15;6:39233
pubmed: 27976705